A study for a 14 year old boy who takes Cotempla Xr-Odt - from FDA reports


2,737 males aged 14 (±5) who take the same drug are studied. This is a personalized study for a 14 year old male patient who has Adhd. The study is created by eHealthMe based on reports from FDA.



On May, 15, 2018

2,737 males aged 14 (±5) who take Cotempla Xr-Odt are studied.


Number of reports submitted per year:

Cotempla Xr-Odt for a 14-year old boy.

Information of the patient in this study:

  • Age: 14
  • Gender: male
  • Conditions: Adhd
  • Drugs taken:
    • Cotempla Xr-Odt (methylphenidate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Drug ineffective
  2. Application site erythema (redness of the skin at application site)
  3. Abnormal behavior
  4. Nausea (feeling of having an urge to vomit)
  5. Application site urticaria
1 - 6 months:
  1. Application site erythema (redness of the skin at application site)
  2. Drug ineffective
  3. Drug administration error
  4. Application site rash
  5. Application site vesicles (small bubble within a cell at application site)
6 - 12 months:
  1. Application site erythema (redness of the skin at application site)
  2. Drug ineffective
  3. Application site pruritus (application site severe itching of the skin)
  4. Disturbance in attention
  5. Vitiligo (pigment is lost from areas of the skin)
1 - 2 years:
  1. Drug ineffective
  2. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  3. Disturbance in attention
  4. Disturbance in social behavior
  5. Application site erythema (redness of the skin at application site)
2 - 5 years:
  1. Disturbance in attention
  2. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  3. Drug ineffective
  4. Disturbance in social behavior
  5. Drug administration error
5 - 10 years:
  1. Disturbance in attention
  2. Psychomotor hyperactivity (feelings of extreme restlessness)
  3. Overdose
  4. Drug effect decreased
  5. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
10+ years:
  1. Irritability
  2. Heart rate increased
  3. Thirst
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
not specified:
  1. Drug administration error
  2. Drug ineffective
  3. Application site erythema (redness of the skin at application site)
  4. Application site pruritus (application site severe itching of the skin)
  5. Disturbance in attention
Click here to get more results

Top conditions involved for these people *:

  1. Stress And Anxiety : 58 people, 2.12%
  2. Hypersensitivity : 40 people, 1.46%
  3. Insomnia (sleeplessness): 33 people, 1.21%
  4. Asthma : 30 people, 1.10%
  5. Sleep Disorder : 25 people, 0.91%
Click here to get more results

Top co-used drugs for these people *:

  1. Intuniv (81 people, 2.96%)
  2. Ritalin (57 people, 2.08%)
  3. Focalin (48 people, 1.75%)
  4. Clonidine (46 people, 1.68%)
  5. Risperdal (45 people, 1.64%)
Click here to get more results

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

What are the drugs?

  • Cotempla xr-odt has active ingredients of methylphenidate.

What are the conditions?



Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Cotempla xr-odt, Adhd

You may be interested in these posts

More posts for: Cotempla xr-odt, Adhd

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.